Profile data is unavailable for this security.
About the company
RaQualia Pharma Inc. is a Japan-based company engaged in the research and development of pharmaceutical products. The Company is mainly engaged in the discovery and research, the preclinical trials and part of clinical trials of drugs, as well as the licensing of developed compounds to pharmaceutical companies. The Company is focused on pain diseases area and intestinal disease area. Its products include EP4 antagonist, cyclooxygenase-2 (COX-2) inhibitory, 5-HT4 portion partial agonist, among others.
- Revenue in JPY (TTM)3.98bn
- Net income in JPY273.12m
- Incorporated2008
- Employees85.00
- LocationRaQualia Pharma Inc8F, Daiwa Meieki Bldg.1-21-19, Meieki-MinamiNakamura-kuNAGOYA-SHI 450-0003JapanJPN
- Phone+81 524466100
- Fax+81 525650700
- Websitehttps://www.raqualia.com
More ▼
Peer analysis
Key Information
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
| Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| CellSeed Inc | 83.68m | -1.10bn | 13.29bn | 38.00 | -- | 9.73 | -- | 158.80 | -31.83 | -31.83 | 2.41 | 35.67 | 0.0409 | 0.6561 | 3.81 | -- | -54.00 | -46.88 | -59.08 | -50.95 | 51.09 | 53.64 | -1,319.46 | -593.85 | 5.81 | -- | 0.0949 | -- | -56.71 | -15.95 | -28.41 | -- | 21.04 | -- |
| Immuno-Biological Laboratories Co., Ltd. | 1.03bn | 363.89m | 15.04bn | 58.00 | 41.33 | 8.53 | 39.35 | 14.58 | 39.07 | 39.07 | 110.76 | 189.25 | 0.5456 | 0.8603 | 4.81 | 17,786,030.00 | 19.25 | -4.96 | 22.46 | -5.77 | 70.35 | 62.70 | 35.27 | -11.27 | 3.96 | 2,702.08 | 0.0947 | -- | 18.71 | 10.95 | 33.40 | -- | -- | -- |
| TAIKO PHARMACEUTICAL CO LTD | 6.40bn | 923.00m | 15.09bn | 214.00 | 16.22 | 1.76 | 12.69 | 2.36 | 18.37 | 18.37 | 127.34 | 169.51 | 0.5080 | 1.77 | 2.62 | -- | 7.34 | -18.99 | 9.32 | -24.04 | 54.42 | 40.20 | 14.44 | -46.31 | 2.72 | -- | 0.0874 | -- | 1.67 | -- | 2.78 | -- | -- | -- |
| CanBas Co Ltd (Parent) | 0.00 | -1.25bn | 16.62bn | 14.00 | -- | 6.99 | -- | -- | -64.11 | -64.11 | 0.00 | 120.62 | 0.00 | -- | -- | 0.00 | -44.48 | -57.04 | -46.19 | -62.13 | -- | -- | -- | -4,587.85 | -- | -566.18 | 0.00 | -- | -- | -- | 4.27 | -- | -- | -- |
| Stella Pharma Corp | 968.76m | -279.32m | 16.88bn | 43.00 | -- | 6.26 | -- | 17.43 | -8.21 | -8.21 | 28.47 | 79.22 | 0.1966 | 0.0944 | 2.91 | 22,529,260.00 | -5.67 | -16.41 | -5.96 | -18.19 | 87.88 | 87.03 | -28.83 | -176.16 | 13.81 | -45.69 | 0.226 | -- | 256.62 | -- | 81.56 | -- | -21.34 | -- |
| ReproCell Inc | 2.52bn | -324.61m | 17.16bn | 99.00 | -- | 1.95 | -- | 6.81 | -3.42 | -3.42 | 26.63 | 92.82 | 0.2328 | 4.15 | 5.92 | 25,450,770.00 | -3.00 | -4.09 | -3.63 | -4.47 | 49.35 | 43.75 | -12.88 | -13.66 | 4.93 | -- | 0.00 | -- | 22.74 | 19.94 | 428.65 | -- | -6.31 | -- |
| StemRIM Inc | 0.00 | -1.90bn | 18.49bn | 45.00 | -- | 2.69 | -- | -- | -30.56 | -30.56 | 0.00 | 109.73 | 0.00 | -- | -- | 0.00 | -24.08 | -12.71 | -24.55 | -12.88 | -- | -- | -- | -167.35 | 47.00 | -- | 0.00 | -- | -- | -- | 4.59 | -- | -22.11 | -- |
| Ohki Healthcare Holdings Co Ltd | 359.41bn | 2.43bn | 19.57bn | 648.00 | 7.80 | 0.5711 | 6.91 | 0.0545 | 178.43 | 178.43 | 26,346.69 | 2,435.83 | 2.26 | 9.83 | 4.34 | 554,637,400.00 | 1.53 | 1.77 | 6.23 | 7.74 | 5.31 | 5.26 | 0.677 | 0.6977 | 0.8306 | -- | 0.2686 | 14.17 | 4.42 | 4.74 | 19.41 | 2.21 | 45.68 | 6.47 |
| Astena Holdings Co Ltd | 62.74bn | 2.19bn | 20.59bn | 1.54k | 9.24 | 0.7468 | 4.47 | 0.3282 | 54.22 | 54.22 | 1,555.72 | 670.84 | 0.8961 | 3.62 | 2.88 | 40,663,640.00 | 3.11 | 0.9587 | 6.26 | 1.76 | 34.85 | 30.40 | 3.47 | 1.05 | 0.9228 | -- | 0.4519 | 114.25 | 8.19 | -0.808 | 186.60 | 1.97 | 12.61 | 2.38 |
| Fuso Pharmaceutical Industries Ltd | 62.17bn | -4.01bn | 23.42bn | 1.34k | -- | 0.6105 | -- | 0.3767 | -469.00 | -469.00 | 7,280.21 | 4,059.08 | 0.7307 | 3.25 | 2.32 | 46,394,780.00 | -4.71 | 0.7682 | -9.76 | 1.29 | 26.39 | 26.94 | -6.44 | 1.05 | 0.8228 | 69.88 | 0.4617 | 106.29 | 9.31 | 5.25 | -338.78 | -- | 4.37 | 6.45 |
| Kubota Pharmaceutical Holdings Co Ltd | 21.34m | -676.25m | 25.04bn | 19.00 | -- | 13.81 | -- | 1,173.79 | -10.91 | -10.91 | 0.3341 | 15.72 | 0.0121 | 3.54 | 7.98 | -- | -38.41 | -44.81 | -42.10 | -49.35 | -14.68 | -- | -3,169.69 | -8,411.59 | 12.49 | -- | 0.0121 | -- | -21.53 | -10.80 | 49.26 | -- | -4.55 | -- |
| RaQualia Pharma Inc | 3.98bn | 273.12m | 25.70bn | 85.00 | 110.18 | 3.50 | 33.76 | 6.46 | 8.97 | 8.97 | 165.54 | 281.96 | 0.3947 | 4.35 | 3.04 | -- | 2.71 | 2.64 | 3.08 | 2.90 | 82.11 | 85.46 | 6.86 | 6.36 | 4.33 | 6.63 | 0.2962 | 0.00 | 28.07 | 29.16 | 155.17 | -- | -13.74 | -- |
| Renascience Inc | 106.94m | -258.99m | 26.16bn | 3.00 | -- | 10.61 | -- | 244.57 | -20.35 | -20.35 | 8.40 | 186.09 | 0.0479 | -- | 4.86 | 35,648,000.00 | -11.59 | -8.97 | -12.40 | -9.35 | 95.94 | 84.44 | -242.17 | -107.53 | -- | -- | 0.00 | -- | -31.66 | 13.00 | 143.91 | -- | -- | -- |
Data as of Mar 04 2026. Currency figures normalised to RaQualia Pharma Inc's reporting currency: Japanese Yen JPY
0.19%Per cent of shares held by top holders
| Holder | Shares | % Held |
|---|---|---|
| Simplex Asset Management Co., Ltd.as of 05 Feb 2026 | 45.50k | 0.19% |
| Connor, Clark & Lunn Investment Management Ltd.as of 30 Jun 2025 | 300.00 | 0.00% |
| LGT Capital Partners AG (Investment Management)as of 31 May 2025 | 0.00 | 0.00% |
Data from 31 Dec 2025 - 19 Feb 2026Source: FactSet Research Systems Inc.
